by Elizabeth Kissling | Oct 11, 2010 | Menorrhagia, Menstruation, New Research, Pharmaceutical
Nearly a year ago, we shared news of FDA approval of tranexamic acid tablets as treatment for heavy menstrual bleeding. Today we learned of successful clinical trials of the drug this purpose: The current issue of Obstetrics & Gynecology includes the results of a...
by Elizabeth Kissling | Sep 19, 2010 | New Research, Pharmaceutical, PMDD, PMS
Some of you may recall that in my book, Capitalizing on the Curse, I argued that the addition of PMDD to the DSM-IV and the re-branding of fluoxetine HCI as Sarafem are linked. It was no coincidence that pharmaceutical manufacturer Eli Lilly sought a unique FDA...
by David Linton | Sep 14, 2010 | Advertising, Internet, Media, Menstruation, Pharmaceutical, Television
The challenge that advertisers face when promoting the sale of menstrual products is how to visually demonstrate how the product works or the aspects of the cycle that product addresses without showing actual menstrual blood or a woman’s anatomy. One well established...
by Chris Hitchcock | Sep 8, 2010 | Menstruation
An open-access article published in PLOS Medicine yesterday, Dr. Adriane Fugh-Berman, associate professor in the Department of Physiology at Georgetown University Medical Center in Washington DC, presents an article describing the ways in which the pharmaceutical...
by Elizabeth Kissling | Aug 30, 2010 | Advertising, Menopause, New Research, Pharmaceutical
Longtime readers may recall that late last year, the New York Times published an essay about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. Despite that exposé and others of the well-documented risks and limited benefits of...